Results 11 to 20 of about 1,905 (147)

Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin [PDF]

open access: yesSexual Medicine, 2022
: Background: The efficacy of flibanserin in treating hypoactive sexual desire disorder (HSDD) is based upon statistically significant improvements in sexual desire, satisfying sexual events, and distress.
James A. Simon, MD   +3 more
doaj   +2 more sources

Using the health belief model to predict those seeking treatment for Hypoactive Sexual Desire Disorder among premenopausal women

open access: diamondTaiwanese Journal of Obstetrics & Gynecology, 2018
Objective: Hypoactive Sexual Desire Disorder (HSDD) was the most common subtype of female sexual dysfunction; however, little was known about why Chinese women with HSDD were willing to seek medical help.
Yin-Jou Chou, Chun-Ming Shih
doaj   +2 more sources

Melanocortin 4 receptor agonism enhances sexual brain processing in women with hypoactive sexual desire disorder [PDF]

open access: yesThe Journal of Clinical Investigation, 2022
BACKGROUND Hypoactive sexual desire disorder (HSDD) is characterized by a persistent deficiency of sexual fantasies and desire for sexual activity, causing marked distress and interpersonal difficulty.
Layla Thurston   +16 more
doaj   +2 more sources

Reliability and validity of the elements of desire questionnaire in premenopausal women with hypoactive sexual desire disorder [PDF]

open access: yesJournal of Patient-Reported Outcomes, 2020
Background The Elements of Desire Questionnaire (EDQ) is a patient-reported outcome (PRO) measure developed to evaluate sexual desire and was included in two identically designed phase 3 clinical trials (RECONNECT) as an exploratory endpoint. The EDQ was
Dennis A. Revicki   +8 more
doaj   +2 more sources

Body Image and Hypoactive Sexual Desire Disorder Relationship in a Representative Sample of Iranian Women [PDF]

open access: yesJournal of Family and Reproductive Health, 2020
Objective: Hypoactive Sexual Desire Disorder (HSDD) among women is a complicated one which is created by various factors playing roles. One of the potential concerns related to Body Image (BI) is lack of sexual appeal in women.
Zeinab Hamzehgardeshi   +4 more
doaj   +2 more sources

International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. [PDF]

open access: bronzeJ Womens Health (Larchmt), 2021
Parish SJ   +13 more
europepmc   +5 more sources

Acupuncture in Premenopausal Women With Hypoactive Sexual Desire Disorder: A Prospective Cohort Pilot Study [PDF]

open access: yesSexual Medicine, 2016
Introduction: Female sexual dysfunction affects up to 43% of women in the United States and hypoactive sexual desire disorder (HSDD) is the most common type; however, we lack treatment options showing improvement for this condition.
Susan H. Oakley, MD, FACOG   +3 more
doaj   +2 more sources

Assessing the Burden of Illness Associated with Acquired Generalized Hypoactive Sexual Desire Disorder. [PDF]

open access: hybridJ Womens Health (Larchmt), 2022
Simon JA   +7 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy